BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36995887)

  • 1. SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).
    Zabot GP; Cassol OS; Quaresma AB; Gonçalves Filho FA; Baima JP; Imbrizi M; Rolim AS; Carmo AMD; Alves Junior AJT; Santos CHMD; Sobrado Junior CW; Miranda EF; Albuquerque IC; Souza MM; Kaiser Junior RL; Parra RS; Kotze PG; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):1-19. PubMed ID: 36995887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
    Lomazi EA; Oba J; Rodrigues M; Marmo MCDR; Sandy NS; Sdepanian VL; Imbrizi M; Baima JP; Magro DO; Albuquerque IC; Zabot GP; Cassol OS; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):85-124. PubMed ID: 36995890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
    Baima JP; Imbrizi M; Andrade AR; Chebli LA; Argollo MC; Queiroz NSF; Azevedo MFC; Vieira A; Costa MHM; Fróes RSB; Penna FGCE; Quaresma AB; Damião AOMC; Moraes ACDS; Santos CHMD; Flores C; Zaltman C; Vilela EG; Morsoletto E; Gonçalves Filho FA; Santana GO; Zabot GP; Parente JML; Sassaki LY; Zerôncio MA; Machado MB; Cassol OS; Kotze PG; Parra RS; Miszputen SJ; Coy CSR; Ambrogini Junior O; Chebli JMF; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):51-84. PubMed ID: 36995889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
    Imbrizi M; Baima JP; Azevedo MFC; Andrade AR; Queiroz NSF; Chebli JMF; Chebli LA; Argollo MC; Sassaki LY; Parra RS; Quaresma AB; Vieira A; Damião AOMC; Moraes ACDS; Flores C; Zaltman C; Vilela EG; Morsoletto EM; Gonçalves Filho FA; Penna FGCE; Santana GO; Zabot GP; Parente JML; Costa MHM; Zerôncio MA; Machado MB; Cassol OS; Kotze PG; Fróes RSB; Miszputen SJ; Ambrogini Junior O; Saad-Hossne R; Coy CSR
    Arq Gastroenterol; 2023; 59(suppl 1):20-50. PubMed ID: 36995888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).
    Romero RK; Magro DO; Queiroz NSF; Damião AOMC; Teixeira FV; Nones RB; Sassaki LY; Saad-Hossne R; Kotze PG
    Gastroenterol Hepatol; 2022; 45(7):499-506. PubMed ID: 34634427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.
    Fróes RSB; Andrade AR; Faria MAG; de Souza HSP; Parra RS; Zaltman C; Dos Santos CHM; Bafutto M; Quaresma AB; Santana GO; Luporini RL; de Lima Junior SF; Miszputen SJ; de Souza MM; Herrerias GSP; Junior RLK; do Nascimento CR; Féres O; de Barros JR; Sassaki LY; Saad-Hossne R
    Sci Rep; 2024 Feb; 14(1):4314. PubMed ID: 38383742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
    ; Ma C; Hanzel J; Panaccione R; Sandborn WJ; D'Haens GR; Ahuja V; Atreya R; Bernstein CN; Bossuyt P; Bressler B; Bryant RV; Cohen B; Colombel JF; Danese S; Dignass A; Dubinsky MC; Fleshner PR; Gearry RB; Hanauer SB; Hart A; Kotze PG; Kucharzik T; Lakatos PL; Leong RW; Magro F; Panés J; Peyrin-Biroulet L; Ran Z; Regueiro M; Singh S; Spinelli A; Steinhart AH; Travis SP; van der Woude CJ; Yacyshyn B; Yamamoto T; Allez M; Bemelman WA; Lightner AL; Louis E; Rubin DT; Scherl EJ; Siegel CA; Silverberg MS; Vermeire S; Parker CE; McFarlane SC; Guizzetti L; Smith MI; Vande Casteele N; Feagan BG; Jairath V
    Gastroenterology; 2022 Oct; 163(4):950-964. PubMed ID: 35788348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
    Lamb CA; Kennedy NA; Raine T; Hendy PA; Smith PJ; Limdi JK; Hayee B; Lomer MCE; Parkes GC; Selinger C; Barrett KJ; Davies RJ; Bennett C; Gittens S; Dunlop MG; Faiz O; Fraser A; Garrick V; Johnston PD; Parkes M; Sanderson J; Terry H; ; Gaya DR; Iqbal TH; Taylor SA; Smith M; Brookes M; Hansen R; Hawthorne AB
    Gut; 2019 Dec; 68(Suppl 3):s1-s106. PubMed ID: 31562236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD.
    Le Berre C; Peyrin-Biroulet L;
    Gastroenterology; 2021 Apr; 160(5):1452-1460.e21. PubMed ID: 33421515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis or Crohn's disease? Pitfalls and problems.
    Feakins RM
    Histopathology; 2014 Feb; 64(3):317-35. PubMed ID: 24266813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position Paper.
    Hanzel J; Bossuyt P; Pittet V; Samaan M; Tripathi M; Czuber-Dochan W; Burisch J; Leone S; Saldaña R; Baert F; Kopylov U; Jäghult S; Adamina M; Arebi N; Gecse K
    J Crohns Colitis; 2023 Apr; 17(3):311-317. PubMed ID: 36190188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
    Ooi CJ; Hilmi I; Banerjee R; Chuah SW; Ng SC; Wei SC; Makharia GK; Pisespongsa P; Chen MH; Ran ZH; Ye BD; Park DI; Ling KL; Ong D; Ahuja V; Goh KL; Sollano J; Lim WC; Leung WK; Ali RAR; Wu DC; Ong E; Mustaffa N; Limsrivilai J; Hisamatsu T; Yang SK; Ouyang Q; Geary R; De Silva JH; Rerknimitr R; Simadibrata M; Abdullah M; Leong RWL;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1296-1315. PubMed ID: 30848854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.
    Yamamoto-Furusho JK; Andrade D; Barahona J; Bautista S; Bosques-Padilla F; de Paula J; Galiano MT; Iade B; Juliao-Baños F; Otoya G; Steinwurz F; Torres E; Veitia G; Barreiro-de Acosta M
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(1):89-102. PubMed ID: 34866040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
    Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical and surgical management of moderate-to-severe inflamatory bowel disease].
    Paredes Méndez JE; Junes Pérez SI; Vargas Marcacuzco HT; Alosilla Sandoval PA; Gutiérrez Córdova IB; Fernández Luque JL; Alvarado Ortiz Blanco E
    Rev Gastroenterol Peru; 2021; 41(2):79-85. PubMed ID: 34724688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.